基于转细胞体的传递在血脑屏障的策略
1Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, 20500 Turku, Finland.
Molecular pharmaceutics
|October 9, 2025
概括
优化大脑输送包括了解大疗法如何与大脑微血管内皮细胞 (BMEC) 相互作用. 调整这些相互作用和血液流的可用性可以增强穿越血脑屏障的细胞转移.
科学领域:
- 神经科学是一个神经科学.
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
背景情况:
- 通过大脑微血管内皮细胞 (BMEC) 进行细胞转移是将生物和纳米载体输送到大脑的关键.
- 大脑吸收的效率受到治疗性质和BMEC传输机制之间的复杂相互作用的影响.
研究的目的:
- 为优化通过血脑屏障输送大型治疗药物的框架提出建议.
- 阐明治疗药物和BMEC表面/细胞内标之间的相互作用,以增强大脑传递.
主要方法:
- 该研究提出了一个概念框架,分析了药物输送的三个关键组成部分:BMEC表面可用性,细胞转移和血液流的可用性.
- 它审查了如何调节与BMEC表面和细胞内蛋白质的相互作用可以改善运输.
主要成果:
- 该框架强调,优化交互可以最大限度地减少非生产性贩运和陷,从而最大限度地提高转细胞化.
- 建议采取提高治疗药物的血液流可用性的策略.
结论:
- 在治疗-BMEC相互作用和血流可用性方面的平衡调整对于改善整体血脑屏障运输至关重要.
- 这种方法为增强向大脑输送大型治疗药物的路线图提供了指导.
相关概念视频
Physiological Barriers
5.0K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.0K
The Blood-brain Barrier
52.3K
Overview
52.3K
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
1.6K
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
1.6K
Cellular Membranes and Drug Transport
1.4K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.4K
Bioavailability Enhancement: Drug Permeability Enhancement
186
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
186
Carrier-Mediated Transport
1.2K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.2K


